AMN Healthcare Services Stock Forecast, Price & News

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AMN Healthcare Services in the last year. There are currently 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AMN Healthcare Services stock.
View analyst ratings for AMN Healthcare Services or view top-rated stocks.

Wall Street analysts have given AMN Healthcare Services a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but AMN Healthcare Services wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

AMN Healthcare Services is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for AMN Healthcare Services.

AMN Healthcare Services, Inc. (NYSE:AMN) announced its quarterly earnings data on Thursday, May, 6th. The company reported $1.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.37 by $0.33. The business earned $885.90 million during the quarter, compared to analysts' expectations of $810.32 million. AMN Healthcare Services had a net margin of 4.78% and a trailing twelve-month return on equity of 25.19%. The business's revenue was up 47.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.79 earnings per share.
View AMN Healthcare Services' earnings history.

AMN Healthcare Services' stock was trading at $68.34 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AMN stock has increased by 40.0% and is now trading at $95.70.
View which stocks have been most impacted by COVID-19.

AMN Healthcare Services issued an update on its second quarter 2021 earnings guidance on Thursday, May, 27th. The company provided EPS guidance of - for the period. The company issued revenue guidance of $810 million-$830 million, compared to the consensus revenue estimate of $712.82 million.

9 Wall Street analysts have issued twelve-month price targets for AMN Healthcare Services' stock. Their forecasts range from $62.00 to $112.00. On average, they anticipate AMN Healthcare Services' share price to reach $86.00 in the next year. This suggests that the stock has a possible downside of 10.1%.
View analysts' price targets for AMN Healthcare Services or view top-rated stocks among Wall Street analysts.

355 employees have rated AMN Healthcare Services CEO Susan R. Salka on Glassdoor.com. Susan R. Salka has an approval rating of 87% among AMN Healthcare Services' employees.

Some companies that are related to AMN Healthcare Services include Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Amedisys (AMED), Chemed (CHE), LHC Group (LHCG), R1 RCM (RCM), MEDNAX (MD), CorVel (CRVL), Tivity Health (TVTY) and Cross Country Healthcare (CCRN).
View all of AMN's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other AMN Healthcare Services investors own include Edwards Lifesciences (EW), Gilead Sciences (GILD), NVIDIA (NVDA), Ultra Clean (UCTT), Alibaba Group (BABA), The Walt Disney (DIS), Johnson & Johnson (JNJ), QUALCOMM (QCOM), AbbVie (ABBV) and CVS Health (CVS).

AMN Healthcare Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "AMN."

AMN Healthcare Services' stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (16.49%), Federated Hermes Inc. (3.22%), Riverbridge Partners LLC (3.10%), Dimensional Fund Advisors LP (2.79%), Price T Rowe Associates Inc. MD (1.83%) and Waddell & Reed Financial Inc. (1.65%). Company insiders that own AMN Healthcare Services stock include Brian M Scott, Denise L Jackson, Douglas D Wheat, Mark Christopher Hagan, Mark G Foletta, Martha H Marsh, Michael M E Johns, Ralph Henderson and Susan R Salka.
View institutional ownership trends for AMN Healthcare Services.

AMN stock was sold by a variety of institutional investors in the last quarter, including Rothschild & Co. Asset Management US Inc., Kennedy Capital Management Inc., Bank of New York Mellon Corp, Tributary Capital Management LLC, Sei Investments Co., Riverbridge Partners LLC, Loomis Sayles & Co. L P, and Nuveen Asset Management LLC. Company insiders that have sold AMN Healthcare Services company stock in the last year include Brian M Scott, Denise L Jackson, Douglas D Wheat, Mark Christopher Hagan, Mark G Foletta, Martha H Marsh, and Susan R Salka.
View insider buying and selling activity for AMN Healthcare Services or view top insider-selling stocks.

AMN stock was acquired by a variety of institutional investors in the last quarter, including Millennium Management LLC, BlackRock Inc., Eaton Vance Management, Federated Hermes Inc., Allianz Asset Management GmbH, Morgan Stanley, Amundi Asset Management US Inc., and Silverleafe Capital Partners LLC.
View insider buying and selling activity for AMN Healthcare Services or or view top insider-buying stocks.

Shares of AMN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AMN stock can currently be purchased for approximately $95.70.

AMN Healthcare Services has a market capitalization of $4.52 billion and generates $2.39 billion in revenue each year. The company earns $70.67 million in net income (profit) each year or $3.43 on an earnings per share basis.

AMN Healthcare Services employs 3,000 workers across the globe.

The official website for AMN Healthcare Services is www.amnhealthcare.com.

AMN Healthcare Services is headquartered at 8840 CYPRESS WATERS BOULEVARD SUITE 300, Dallas TX, 75019.

AMN Healthcare Services' mailing address is 8840 CYPRESS WATERS BOULEVARD SUITE 300, Dallas TX, 75019. The company can be reached via phone at 866-871-8519 or via email at [email protected]